Clinical Trial Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product and Service (Trial Design Consulting Services, Read Analysis Services, Operational Imaging Services, Imaging Software), By Modality (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, Other Modalities), By End-User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic and Government Research Institute), By Region, By Competition, 2020-2030F
The Global Clinical Trial Imaging Market, valued at USD 1.18 Billion in 2024, is projected to experience a CAGR of 7.30% to reach USD 1.80 Billion by 2030. The clinical trial imaging market encompasses the application of medical imaging modalities, such as Magnetic Resonance Imaging, Computed Tomography, and Positron Emission Tomography, to objectively assess the safety and efficacy of investigational therapeutics throughout clinical development.
Key Market Drivers
The increasing global clinical trial volume is a fundamental driver for the clinical trial imaging market as pharmaceutical and biotechnology companies expand therapeutic pipelines. This expansion necessitates comprehensive imaging for drug safety and efficacy assessments, directly increasing demand for specialized services. This growth is evidenced by the rising number of registered studies; according to ClinicalTrials. gov, as of October 10, 2025, the number of registered studies reached 74,339.
Key Market Challenges
The substantial capital expenditure required for imaging equipment directly impedes the growth of the Global Clinical Trial Imaging Market. The high cost of acquiring and maintaining advanced medical imaging modalities, such as Magnetic Resonance Imaging or Positron Emission Tomography systems, places a significant financial burden on clinical trial sites and contract research organizations. This barrier limits the ability of many entities, particularly smaller or emerging research centers, to invest in the latest technology or expand their imaging capabilities.
Key Market Trends
The adoption of decentralized and hybrid clinical trial models is fundamentally reshaping operational strategies within the global clinical trial imaging market by enhancing patient accessibility and streamlining data collection. This approach integrates remote technologies such as telemedicine and wearable devices, reducing the need for extensive on-site patient visits and thereby broadening the geographic reach for participant recruitment. TransCelerate BioPharma's 2024 Annual Report indicates that both mature and newer initiatives have achieved 75% or higher adoption rates among their member companies in recent years, reflecting the increasing integration of flexible trial designs.
Key Market Players
In this report, the Global Clinical Trial Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Global Clinical Trial Imaging Market.
Available Customizations:
Global Clinical Trial Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
The increasing global clinical trial volume is a fundamental driver for the clinical trial imaging market as pharmaceutical and biotechnology companies expand therapeutic pipelines. This expansion necessitates comprehensive imaging for drug safety and efficacy assessments, directly increasing demand for specialized services. This growth is evidenced by the rising number of registered studies; according to ClinicalTrials. gov, as of October 10, 2025, the number of registered studies reached 74,339.
Key Market Challenges
The substantial capital expenditure required for imaging equipment directly impedes the growth of the Global Clinical Trial Imaging Market. The high cost of acquiring and maintaining advanced medical imaging modalities, such as Magnetic Resonance Imaging or Positron Emission Tomography systems, places a significant financial burden on clinical trial sites and contract research organizations. This barrier limits the ability of many entities, particularly smaller or emerging research centers, to invest in the latest technology or expand their imaging capabilities.
Key Market Trends
The adoption of decentralized and hybrid clinical trial models is fundamentally reshaping operational strategies within the global clinical trial imaging market by enhancing patient accessibility and streamlining data collection. This approach integrates remote technologies such as telemedicine and wearable devices, reducing the need for extensive on-site patient visits and thereby broadening the geographic reach for participant recruitment. TransCelerate BioPharma's 2024 Annual Report indicates that both mature and newer initiatives have achieved 75% or higher adoption rates among their member companies in recent years, reflecting the increasing integration of flexible trial designs.
Key Market Players
- Clario Medical Imaging Inc
- Icon PLC
- Ixico PLC
- Koninklijke Philips N.V
- Medpace
- Navitas Clinical Research, Inc
- Parexel International Corporation
- ProScan Imaging
- Radiant Sage LLC
- Resonance Health
In this report, the Global Clinical Trial Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Clinical Trial Imaging Market, By Product and Service:
- Trial Design Consulting Services
- Read Analysis Services
- Operational Imaging Services
- Imaging Software
- Clinical Trial Imaging Market, By Modality:
- Magnetic Resonance Imaging
- Computed Tomography
- Ultrasound
- Positron Emission Tomography
- X-Ray
- Echocardiography
- Other Modalities
- Clinical Trial Imaging Market, By End User:
- Pharmaceutical & Biotechnology Companies
- Medical Device Manufacturers
- Academic and Government Research Institute
- Clinical Trial Imaging Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies presents in the Global Clinical Trial Imaging Market.
Available Customizations:
Global Clinical Trial Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL CLINICAL TRIAL IMAGING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product and Service (Trial Design Consulting Services, Read Analysis Services, Operational Imaging Services, Imaging Software)
5.2.2. By Modality (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, Other Modalities)
5.2.3. By End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic and Government Research Institute)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. NORTH AMERICA CLINICAL TRIAL IMAGING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product and Service
6.2.2. By Modality
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Clinical Trial Imaging Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product and Service
6.3.1.2.2. By Modality
6.3.1.2.3. By End User
6.3.2. Canada Clinical Trial Imaging Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product and Service
6.3.2.2.2. By Modality
6.3.2.2.3. By End User
6.3.3. Mexico Clinical Trial Imaging Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product and Service
6.3.3.2.2. By Modality
6.3.3.2.3. By End User
7. EUROPE CLINICAL TRIAL IMAGING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product and Service
7.2.2. By Modality
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Clinical Trial Imaging Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product and Service
7.3.1.2.2. By Modality
7.3.1.2.3. By End User
7.3.2. France Clinical Trial Imaging Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product and Service
7.3.2.2.2. By Modality
7.3.2.2.3. By End User
7.3.3. United Kingdom Clinical Trial Imaging Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product and Service
7.3.3.2.2. By Modality
7.3.3.2.3. By End User
7.3.4. Italy Clinical Trial Imaging Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product and Service
7.3.4.2.2. By Modality
7.3.4.2.3. By End User
7.3.5. Spain Clinical Trial Imaging Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product and Service
7.3.5.2.2. By Modality
7.3.5.2.3. By End User
8. ASIA PACIFIC CLINICAL TRIAL IMAGING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product and Service
8.2.2. By Modality
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Clinical Trial Imaging Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product and Service
8.3.1.2.2. By Modality
8.3.1.2.3. By End User
8.3.2. India Clinical Trial Imaging Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product and Service
8.3.2.2.2. By Modality
8.3.2.2.3. By End User
8.3.3. Japan Clinical Trial Imaging Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product and Service
8.3.3.2.2. By Modality
8.3.3.2.3. By End User
8.3.4. South Korea Clinical Trial Imaging Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product and Service
8.3.4.2.2. By Modality
8.3.4.2.3. By End User
8.3.5. Australia Clinical Trial Imaging Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product and Service
8.3.5.2.2. By Modality
8.3.5.2.3. By End User
9. MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product and Service
9.2.2. By Modality
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Clinical Trial Imaging Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product and Service
9.3.1.2.2. By Modality
9.3.1.2.3. By End User
9.3.2. UAE Clinical Trial Imaging Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product and Service
9.3.2.2.2. By Modality
9.3.2.2.3. By End User
9.3.3. South Africa Clinical Trial Imaging Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product and Service
9.3.3.2.2. By Modality
9.3.3.2.3. By End User
10. SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product and Service
10.2.2. By Modality
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Clinical Trial Imaging Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product and Service
10.3.1.2.2. By Modality
10.3.1.2.3. By End User
10.3.2. Colombia Clinical Trial Imaging Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product and Service
10.3.2.2.2. By Modality
10.3.2.2.3. By End User
10.3.3. Argentina Clinical Trial Imaging Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product and Service
10.3.3.2.2. By Modality
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL CLINICAL TRIAL IMAGING MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Clario Medical Imaging Inc
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Icon PLC
15.3. Ixico PLC
15.4. Koninklijke Philips N.V
15.5. Medpace
15.6. Navitas Clinical Research, Inc
15.7. Parexel International Corporation
15.8. ProScan Imaging
15.9. Radiant Sage LLC
15.10. Resonance Health
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL CLINICAL TRIAL IMAGING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product and Service (Trial Design Consulting Services, Read Analysis Services, Operational Imaging Services, Imaging Software)
5.2.2. By Modality (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, Other Modalities)
5.2.3. By End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic and Government Research Institute)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. NORTH AMERICA CLINICAL TRIAL IMAGING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product and Service
6.2.2. By Modality
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Clinical Trial Imaging Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product and Service
6.3.1.2.2. By Modality
6.3.1.2.3. By End User
6.3.2. Canada Clinical Trial Imaging Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product and Service
6.3.2.2.2. By Modality
6.3.2.2.3. By End User
6.3.3. Mexico Clinical Trial Imaging Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product and Service
6.3.3.2.2. By Modality
6.3.3.2.3. By End User
7. EUROPE CLINICAL TRIAL IMAGING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product and Service
7.2.2. By Modality
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Clinical Trial Imaging Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product and Service
7.3.1.2.2. By Modality
7.3.1.2.3. By End User
7.3.2. France Clinical Trial Imaging Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product and Service
7.3.2.2.2. By Modality
7.3.2.2.3. By End User
7.3.3. United Kingdom Clinical Trial Imaging Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product and Service
7.3.3.2.2. By Modality
7.3.3.2.3. By End User
7.3.4. Italy Clinical Trial Imaging Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product and Service
7.3.4.2.2. By Modality
7.3.4.2.3. By End User
7.3.5. Spain Clinical Trial Imaging Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product and Service
7.3.5.2.2. By Modality
7.3.5.2.3. By End User
8. ASIA PACIFIC CLINICAL TRIAL IMAGING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product and Service
8.2.2. By Modality
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Clinical Trial Imaging Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product and Service
8.3.1.2.2. By Modality
8.3.1.2.3. By End User
8.3.2. India Clinical Trial Imaging Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product and Service
8.3.2.2.2. By Modality
8.3.2.2.3. By End User
8.3.3. Japan Clinical Trial Imaging Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product and Service
8.3.3.2.2. By Modality
8.3.3.2.3. By End User
8.3.4. South Korea Clinical Trial Imaging Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product and Service
8.3.4.2.2. By Modality
8.3.4.2.3. By End User
8.3.5. Australia Clinical Trial Imaging Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product and Service
8.3.5.2.2. By Modality
8.3.5.2.3. By End User
9. MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product and Service
9.2.2. By Modality
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Clinical Trial Imaging Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product and Service
9.3.1.2.2. By Modality
9.3.1.2.3. By End User
9.3.2. UAE Clinical Trial Imaging Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product and Service
9.3.2.2.2. By Modality
9.3.2.2.3. By End User
9.3.3. South Africa Clinical Trial Imaging Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product and Service
9.3.3.2.2. By Modality
9.3.3.2.3. By End User
10. SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product and Service
10.2.2. By Modality
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Clinical Trial Imaging Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product and Service
10.3.1.2.2. By Modality
10.3.1.2.3. By End User
10.3.2. Colombia Clinical Trial Imaging Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product and Service
10.3.2.2.2. By Modality
10.3.2.2.3. By End User
10.3.3. Argentina Clinical Trial Imaging Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product and Service
10.3.3.2.2. By Modality
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL CLINICAL TRIAL IMAGING MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Clario Medical Imaging Inc
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Icon PLC
15.3. Ixico PLC
15.4. Koninklijke Philips N.V
15.5. Medpace
15.6. Navitas Clinical Research, Inc
15.7. Parexel International Corporation
15.8. ProScan Imaging
15.9. Radiant Sage LLC
15.10. Resonance Health
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
